Anaptys to Present Phase 1 Data on ANB032, its BTLA Agonist
SAN DIEGO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative...
Source: globenewswire.com
Stay updated with breaking news from Global Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SAN DIEGO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative...
A pioneering new AI tool from Global Study is seeking to reshape international student management for agencies.
International education opportunities expose college students to foreign cultures, language immersion and interaction with diverse communities around the world…
Scoop Community provides New Zealand Community news and views
Business Scoop provides news and views on Business and Markets from New Zealand